Although the association between certain non-chemotherapy drugs and agranulocytosis has been documented, a comprehensive analysis using a large-scale pharmacovigilance database is lacking. This study ...
This study used the latest reported data from the FDA's Adverse Event Reporting System (FAERS) database to evaluate AEs associated with the use of vortioxetine in FAERS from Q3 2013 to Q1 2024 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback